EFPIA - NEWSLETTER

EFPIA Newsletter 29 September 2022

News

28 September 2022 ‘TEE’ system will revitalise antibiotic research and save money for Europe, new evidence shows...

New and novel antibiotics are urgently needed to help tackle the global health threat of antimicrobial resistance (AMR),...

Blogs

27 September 2022 We won’t rest until we improve outcomes for patients with even the most resistant leukaemias...

As haematological cancer outcomes and survival rates continue to improve worldwide thanks to earlier diagnosis and advances...

23 September 2022 A spotlight on solid tumours: exploring the impact of a prostate, bladder or lung cancer diagnosis...

Dr Cathy Taylor, Vice President EMEA Medical Affairs, Therapy Area Strategy at Janssen discusses how a diagnosis with...

Events

03 OCT 2022

New procedures and policies for the electronic Certificate of Pharmaceutical Product... Virtual event

With the participation of WHO and global regulators.

Learn more →

10 NOV 2022

Investor Perspective: The Strategic Venturing Spectrum Hybrid

Webinar by Johnson & Johnson Innovation

Learn more →

15 NOV 2022

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION Brussels

An EU Health Coalition event

Learn more →

12 DEC 2022

Enhancing patient-centric outcome measures and clinical trials with Digital Health... Virtual event

Last chance to register!

Learn more →

We are #MorethanMedicine

Medicines have added 1.2m years to the lives of breast cancer patients. But life-saving medicines are just the start of our work.
Find out more

What we are reading

SAATELLITE-2 Includes 1st Patient 29 September 2022 (COMBACTE)

Using real world data (RWD) from patient databases to understand who could benefit from treatment... 07 September 2022 (Data Saves Lives)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶